Sep 05, 2023 / 03:30PM GMT
Operator
Good afternoon, ladies and gentlemen. Welcome to the Tissue Regenix Group plc interim results investor presentation. (Operator Instructions) Before we begin, we'd like to submit the following poll if you could give that your kind attention, I'm sure the company would be most grateful. It's been great pleasure to hand over to CEO, Daniel Lee. Good afternoon.
Daniel Lee - Tissue Regenix Group plc - CEO
Good afternoon, everyone. Thank you for joining us and spending some time with us as we would like to share with you an update on Tissue Regenix and our performance during the first half of 2023. Again, we'll talk about our activities, some of the successful results, and our plans to -- our continuing plans for the future. Disclaimer slide, that should be reviewed by all.
And then, your presenters today are myself, I'm Daniel Lee, I'm the Chief Executive Officer for Tissue Regenix. I was appointed CEO in November of 2020, but I originally joined the organization as the President of US Operations in January 2019 of the CellRight division, which was an
Half Year 2023 Tissue Regenix Group PLC Earnings Call Transcript
Sep 05, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers